Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease
Frédéric Dallaire(Centre Hospitalier Universitaire de Sherbrooke), Rosie Scuccimarri(Montreal Children's Hospital), Anita Dhanrajani(Center for Rheumatology), Audrey Dionne(Boston Children's Hospital), Dania Basodan(Montreal Children's Hospital), Harrison Saulnier(Montreal Children's Hospital), Soha Rached-d’Astous(Centre Hospitalier Universitaire Sainte-Justine), Brian W. McCrindle(University of Toronto), Samuel Blais(Université de Sherbrooke), Astrid M. De Souza(University of British Columbia), Kimberley Kaspy(Montreal Children's Hospital), Derek G. Human(University of British Columbia), Zoe Fortier-Morissette(Université de Sherbrooke), Joël Blanchard(Université de Sherbrooke), Nagib Dahdah(Centre Hospitalier Universitaire Sainte-Justine), Mathew Mathew(University of Toronto), Claudia Renaud
Cited by 89
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
The Agenda for Familial Hypercholesterolemia
|Circulation|2015|726
Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents
|Hypertension|2009|633
Reduced Fetal Cerebral Oxygen Consumption Is Associated With Smaller Brain Size in Fetuses With Congenital Heart Disease
|Circulation|2015|530
Contemporary Outcomes After the Fontan Procedure
|Journal of the American College of Cardiology|2008|441